1-g FC tab and Susp: No adverse effects were observed in pregnant rats and mice when amoxicillin and Clavulanate Potassium combination was administered at doses equivalent to 10 times the usual human dose. There is limited experience on the use of amoxicillin and clavulanate combination in human pregnancy. As with all medicines, use should be avoided in pregnancy, especially during the first trimester, unless considered essential by the physician.
Amoxicillin and Clavulanate Potassium combination can be administered to nursing mothers; no specific adverse event other than risk of sensitization for the infant has been reported.
Other Services
Country
Account